BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 21386704)

  • 1. Spindle cell thymomas: an immunohistochemical study of 30 cases.
    Weissferdt A; Hernandez JC; Kalhor N; Moran CA
    Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):329-35. PubMed ID: 21386704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of calretinin and other mesothelioma-related markers in thymic carcinoma and thymoma.
    Pan CC; Chen PC; Chou TY; Chiang H
    Hum Pathol; 2003 Nov; 34(11):1155-62. PubMed ID: 14652817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymic carcinoma arising in thymoma is associated with alterations in immunohistochemical profile.
    Kuo TT; Chan JK
    Am J Surg Pathol; 1998 Dec; 22(12):1474-81. PubMed ID: 9850173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary thymic epithelial tumours of the pleura mimicking malignant mesothelioma.
    Attanoos RL; Galateau-Salle F; Gibbs AR; Muller S; Ghandour F; Dojcinov SD
    Histopathology; 2002 Jul; 41(1):42-9. PubMed ID: 12121236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ectopic hamartomatous thymoma: a clinicopathological and immunohistochemical study of two cases].
    Wang J; Zhang RY
    Zhonghua Bing Li Xue Za Zhi; 2005 Jul; 34(7):397-401. PubMed ID: 16251042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desmoplastic spindle cell thymomas: a clinicopathologic and immunohistochemical study of 14 cases.
    Weissferdt A; Moran CA
    Hum Pathol; 2013 Apr; 44(4):623-7. PubMed ID: 23084585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation].
    Szczepulska-Wójcik E; Langfort R; Roszkowski-Sliz K
    Pneumonol Alergol Pol; 2007; 75(1):57-69. PubMed ID: 17541913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenomatoid spindle cell thymomas: a clinicopathological and immunohistochemical study of 20 cases.
    Weissferdt A; Kalhor N; Suster S; Moran CA
    Am J Surg Pathol; 2010 Oct; 34(10):1544-9. PubMed ID: 20852406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of apoptosis-related markers and HER-2/neu in thymic epithelial tumours.
    Pan CC; Chen PC; Wang LS; Lee JY; Chiang H
    Histopathology; 2003 Aug; 43(2):165-72. PubMed ID: 12877732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical staining for bcl-2 and mcl-1 in intrathyroidal epithelial thymoma (ITET)/carcinoma showing thymus-like differentiation (CASTLE) and cervical thymic carcinoma.
    Dorfman DM; Shahsafaei A; Miyauchi A
    Mod Pathol; 1998 Oct; 11(10):989-94. PubMed ID: 9796728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solitary fibrous tumor of the thymus with variegated epithelial components.
    Tsubochi H; Endo T; Sogabe M; Endo S; Morinaga S; Dobashi Y
    Int J Clin Exp Pathol; 2014; 7(11):7477-84. PubMed ID: 25550783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathologic classification of lung cancer: Relevance of cytokeratin and TTF-1 immunophenotyping.
    Johansson L
    Ann Diagn Pathol; 2004 Oct; 8(5):259-67. PubMed ID: 15494931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiating the undifferentiated: immunohistochemical profile of medullary carcinoma of the colon with an emphasis on intestinal differentiation.
    Winn B; Tavares R; Fanion J; Noble L; Gao J; Sabo E; Resnick MB
    Hum Pathol; 2009 Mar; 40(3):398-404. PubMed ID: 18992917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression patterns for Bcl-2, EMA, β-catenin, E-cadherin, PAX8, and MIB1 in thymomas.
    Suster D; Miller JA; Pihan G; Mackinnon AC; Suster S
    Mod Pathol; 2021 Oct; 34(10):1831-1838. PubMed ID: 34135467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine Differentiation in Thymic Carcinomas: A Diagnostic Pitfall: An Immunohistochemical Analysis of 27 Cases.
    Weissferdt A; Moran CA
    Am J Clin Pathol; 2016 Mar; 145(3):393-400. PubMed ID: 27124922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis, bcl-2 protein, and Fas antigen in thymic epithelial tumors.
    Tateyama H; Eimoto T; Tada T; Inagaki H; Hattori H; Takino H
    Mod Pathol; 1997 Oct; 10(10):983-91. PubMed ID: 9346177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immunohistochemical study of metaplastic spindle cell carcinoma, phyllodes tumor and fibromatosis of the breast.
    Dunne B; Lee AH; Pinder SE; Bell JA; Ellis IO
    Hum Pathol; 2003 Oct; 34(10):1009-15. PubMed ID: 14608534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An immunohistochemical analysis of ovarian small cell carcinoma of hypercalcemic type.
    McCluggage WG; Oliva E; Connolly LE; McBride HA; Young RH
    Int J Gynecol Pathol; 2004 Oct; 23(4):330-6. PubMed ID: 15381902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferative activity and apoptosis in thymic epithelial neoplasms.
    Hiroshima K; Iyoda A; Toyozaki T; Supriatna Y; Shibuya K; Shimamura F; Haga Y; Yoshida S; Fujisawa T; Ohwada H
    Mod Pathol; 2002 Dec; 15(12):1326-32. PubMed ID: 12481014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic utility of thymic epithelial markers CD205 (DEC205) and Foxn1 in thymic epithelial neoplasms.
    Nonaka D; Henley JD; Chiriboga L; Yee H
    Am J Surg Pathol; 2007 Jul; 31(7):1038-44. PubMed ID: 17592270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.